Seeing Is Believing
with an average price target of $11.3. This is a potential upside of $11.3 (0%) from yesterday's end of day stock price of $0.
Stemline Therapeutics's activity chart (see below) currently has 42 price targets and 41 ratings on display.
Analysts average stock forecasts to be materialized ratio is 11.79% with an average time for these price targets to be met of 101.43 days.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 05-May-2020. First documented stock forecast 29-Aug-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Jun-2016
$12.5
$0.67 (5.66%)
5 years 9 months ago
(05-May-2020)
0/4 (0%)
$0.41 (3.39%)
Buy Since 17-Mar-2015
$11
$-0.83 (-7.02%)
5 years 9 months 1 days ago
(04-May-2020)
1/5 (20%)
$-1.11 (-9.17%)
623
Hold Since 04-May-2020
$10
5 years 9 months 1 days ago
(04-May-2020)
1/2 (50%)
$5.6 (127.27%)
38
Buy Since 06-Aug-2019
$9
$-2.83 (-23.92%)
$25
5 years 10 months 20 days ago
(16-Mar-2020)
1/8 (12.5%)
$4.94 (121.67%)
49
$23
$11.17 (94.42%)
$23
9 years 2 days ago
(03-Feb-2017)
0/4 (0%)
$16.45 (251.15%)
What is STML (Stemline Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on STML (Stemline Therapeutics) with a proven track record?
Which analyst has the current lower performing score on STML (Stemline Therapeutics) with a proven track record?
Which analyst has the most public recommendations on STML (Stemline Therapeutics)?
Which analyst is the currently most bullish on STML (Stemline Therapeutics)?
Which analyst is the currently most reserved on STML (Stemline Therapeutics)?